Image Sourced Shutterstock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Digital health group 1st Group has entered a new two year agreement with Bodycare Workplace Solutions
  • This agreement will see 1st Group’s solution, MyHealth1st, integrated to 130 physiotherapy and GP practices throughout Australia
  • Implementation of these services will be offered over several phases and is expected to be completed within six months

1st Group has signed an agreement with Bodycare Workplace Solutions to bring MyHealth1st to 130 physiotherapy and GP practices throughout Australia.

Bodycare manages over 70,000 employees, treats more than 115,000 onsite injuries, and attends more than 400,000 appointments each year.

Bodycare is one of Australia’s leading providers of occupational health services and solutions. Since 2000 its mission has been to assist organisations in building healthy and strong workforces.

This is done by providing holistic occupational health services that work with leading technology and software systems.

By using the MyHealth1st platform, Bodycare will be able to provide their customers a seamless and more efficient process for patients to access their services.

MyHealth1st provides a convenient, easy to use platform that offers a way for patients to book their appointments online anytime of the day.

Since its launch in 2012, more than eight million appointments have been booked using the app.

Under the agreement, Bodycare will use the MyHealth1st platform to deliver additional patient flow and service promotion to the 130 practices using the system.

The two year agreement will provide a combination of setup, subscription, and booking fees, with Bodycare having the option of signing up to additional products such as EasyRecalls and EasyFeedback.

Implementation of the services will be offered over several phases and is expected to be completed within six months.

In light of this agreement, 1st Group shares are up nine per cent at 11:25am AEST, trading for 10.3 cents with a market cap of $33.40 million.

1ST by the numbers
More From The Market Online

PharmAust CEO’s sayanora triggers stock plunge

Clinical-stage biotechnology company, PharmAust shares plunged 24 per cent so this morning, following the resignation of…

Emyria locks in $2.3M to progress MDMA research – with Chair adding $0.3M

WA-based and ASX-listed Emyria is seeking to further research using MDMA to treat PTSD. The chair…

Genetic Signatures wins TGA greenlight for flu test device – just before winter

Genetic Signatures (ASX:GSS) shares were down -1.45% to 68cps on Monday, even as the company reported…

PYC Therapeutics takes Polycystic Kidney Disease drug to human trials

PYC Therapeutics takes its latest drug for Polycystic Kidney Disease, characterized by the formation of cysts…